久久99热狠狠色一区二区,新一级毛片国语版,国产综合色精品一区二区三区,日本一区二区免费高清视频,久久vs国产综合色大全,精品国产91久久久久久久a,日本一区二区不卡久久入口

產(chǎn)品分類導(dǎo)航
CPHI制藥在線 資訊 引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

作者:PharmaSourcesInsig  來源:CPhI制藥在線
  2023-04-28
Your FREE source of news and insights into China pharmaceutical industry!

Pharma Sources Insight

       Pharma Sources Insight

       Your FREE source of news and insights into China pharmaceutical industry, and more!

掃碼開始閱讀 Scan to view the full contents.

掃碼開始閱讀

Scan to view the full contents.

Pharma Sources Insight

August 2021

       Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

       Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

 

       Pharma Sources Insight August 2021 focuses on the following topics:

       ?BRAND STORY

       -Product Lists of Nanjing Foreign Economic & Trade Development Co., Ltd.

       ?FIGHTING AGAINST 

          COVID-19

       -Which One of the New Dosage Forms of Nasal Spray Vaccine for COVID-19 Will Be Successful?

       -Overview of COVID-19 Vaccination in Progress in China

       -Having Applied for IPO to HKEX, What to Expect on Advaccine R&D Pipelines beyond COVID-19 DNA Vaccine

       -Science of Epidemiology: Digital Technologies Shaping Our Lives

       ?GLOBAL MARKET REVIEW

       -Alzheimer’s Disease - Recent Advances in Treatment

       -India’s Pharmaceutical Industry Disruption Impacts Africa and the World

       ?PHARMA IN CHINA

       -Popular Products and Suppliers at PharmaSources.com

       -Overseas Marketing of Furmonertinib Following Avitinib and Almonertinib

       -Bispecific Antibodies – Key Developments in China

       ?INDUSTRY INSIGHT

       -A Brief Introduction About FDA Next Step Inspections

往期回顧

August 2021

Pharma Sources Insight April 2021

第五期:https://flbook.com.cn/c/UvEylKXA3d

Pharma Sources Insight January2021

第四期:https://flbook.com.cn/c/hiKJryuATA

第二十一屆世界制藥原料中國展

合作咨詢

   肖女士    021-33392297    Kelly.Xiao@imsinoexpo.com

2006-2024 上海博華國際展覽有限公司版權(quán)所有(保留一切權(quán)利) 滬ICP備05034851號-57